LG Energy Solution Surges on Major US Battery Storage Deal EasyJet Assures Summer Flight Schedule Unaffected by Jet Fuel Supply Concerns Post Office Horizon Scandal Inquiry Faces FiveYear Delay Without Extra Funding Police Warn Venezuela Taps Socialist Banker Matthieu Pigasse to Navigate Financial Crisis and Lure Investors Wingstop Shares Decline 12 as Latest Quarterly Profit Misses Analyst Expectations Dave Ramsey Scolds 100K Earner For Blaming Mother Over 65K Student Loan Debt Shes A Dog She Aint Going To Climb A Tree Espey Mfg Electronics Corp Q1 2026 Earnings EPS Surges Past Estimates with 114 Beat Stem Inc Q1 2026 Earnings EPS Surprises to the Upside as Stock Rises PAYO Q1 2026 Earnings EPS Surpasses Estimates by 3245 Shares Edge Lower RBLX Q1 2026 Earnings EPS Beat Drives Positive Market Reaction GoDaddy GDDY Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Nuburu Q3 2023 Earnings Narrowed Loss and Strategic Progress Drive Sentiment ATIF Holdings ZBAI Holds Flat at 895 as Traders Assess Key Levels Charter Communications CHTR Holds Near Support as Modest Decline Continues Massimo Group MAMO Slides to 098 Navigating Support as Selling Pressure Intensifies Woodside Energy Group WDS Edges Higher at 2177 as Support and Resistance Levels Define a Consolidation Zone Doximity DOCS Rebounds Up 38 as Stock Tests Key Resistance Levels SpaceXs Path to Public Markets Likely Tied to Starlink Revenue Growth IPO Filing Suggests US Stock Futures and Bond Yields Decline on Reports of Putins Updated Nuclear Doctrine SEC Advances Proposal to End Mandatory Quarterly Earnings Reports Backed by Trump US Secretary of State Marco Rubio Navigates CubanAmerican Backlash Amid Push for Economic Deal with Havana US FirstQuarter GDP Growth Revised Lower to 16 Pace New York Fed Study Reveals LowerIncome Households Bear Brunt of Rising Gas Prices Spotify Surges on AI Deal with Universal Music and LongTerm Revenue Guidance EPRT Q1 2026 Earnings EPS Misses Estimates Amidst Operational Adjustments InMed Pharmaceuticals INM Shares Slide Over 3 as Biotech Volatility Intensifies